The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Wiinberg Ulf | Director | Grant(A) | 1K | $10.95 | $14K |
| Sep 1, 2026 | Behner Peter | Director | Grant(A) | 1K | $10.95 | $16K |
| Sep 1, 2026 | Holcomb John Bradley | Director | Grant(A) | 1K | $10.95 | $14K |
| Sep 1, 2026 | Corvese Brian | Director | Grant(A) | 2K | $10.95 | $18K |
| Sep 1, 2026 | Ryan Barbara | Director | Grant(A) | 2K | $10.95 | $18K |
| Jun 4, 2026 | Ryan Barbara | Director | Sell(S) | 500 | $12.68 | $6K |
| Jun 4, 2026 | Ryan Barbara | Director | Sell(S) | 1K | $12.80 | $13K |
| Jun 1, 2026 | Behner Peter | Director | Grant(A) | 1K | $12.38 | $16K |
| Jun 1, 2026 | Corvese Brian | Director | Grant(A) | 1K | $12.38 | $18K |
| Jun 1, 2026 | Wiinberg Ulf | Director | Grant(A) | 1K | $12.38 | $14K |
| Jun 1, 2026 | Ryan Barbara | Director | Grant(A) | 1K | $12.38 | $18K |
| Jun 1, 2026 | Holcomb John Bradley | Director | Grant(A) | 1K | $12.38 | $14K |
| Mar 10, 2026 | Ryan Barbara | Director | Sell(S) | 500 | $15.30 | $8K |
| Mar 10, 2026 | Ryan Barbara | Director | Sell(S) | 500 | $15.57 | $8K |
| Mar 10, 2026 | Ryan Barbara | Director | Sell(S) | 300 | $15.28 | $5K |
| Mar 9, 2026 | Ryan Barbara | Director | Sell(S) | 200 | $10.17 | $2K |
| Mar 2, 2026 | Ryan Barbara | Director | Sell(S) | 100 | $10.83 | $1K |
| Mar 2, 2026 | Behner Peter | Director | Grant(A) | 1K | $10.90 | $16K |
| Mar 2, 2026 | Corvese Brian | Director | Grant(A) | 2K | $10.90 | $18K |
| Mar 2, 2026 | Wiinberg Ulf | Director | Grant(A) | 1K | $10.90 | $14K |
| Mar 2, 2026 | Ryan Barbara | Director | Grant(A) | 2K | $10.90 | $18K |
| Mar 2, 2026 | Holcomb John Bradley | Director | Grant(A) | 1K | $10.90 | $14K |
| Feb 27, 2026 | Ryan Barbara | Director | Sell(S) | 400 | $10.86 | $4K |
| Jan 2, 2026 | Behner Peter | Director | Grant(A) | 5K | — | $0 |
| Jan 2, 2026 | Corvese Brian | Director | Grant(A) | 5K | — | $0 |
| Jan 2, 2026 | Ryan Barbara | Director | Grant(A) | 5K | — | $0 |
| Jan 2, 2026 | Wiinberg Ulf | Director | Grant(A) | 5K | — | $0 |
| Jan 2, 2026 | Buell Jennifer | Chief Executive Officer | Tax withholding(F) | 10K | $11.12 | $111K |
| Dec 1, 2025 | Wiinberg Ulf | Director | Grant(A) | 1K | $11.09 | $14K |
| Dec 1, 2025 | Kadlec Robert Peter | Director | Grant(A) | 1K | $11.09 | $14K |
| Dec 1, 2025 | Ryan Barbara | Director | Grant(A) | 2K | $11.09 | $18K |
| Dec 1, 2025 | Holcomb John Bradley | Director | Grant(A) | 1K | $11.09 | $13K |
| Dec 1, 2025 | Behner Peter | Director | Grant(A) | 1K | $11.09 | $16K |
| Dec 1, 2025 | Corvese Brian | Director | Grant(A) | 2K | $11.09 | $18K |
| Sep 23, 2025 | Holcomb John Bradley | Director | Grant(A) | 4K | — | $0 |
| Sep 9, 2025 | Buell Jennifer | Chief Executive Officer | Tax withholding(F) | 5K | $15.36 | $82K |
| Sep 9, 2025 | Ryan Barbara | Director | Grant(A) | 3K | — | $0 |
| Sep 9, 2025 | Wiinberg Ulf | Director | Grant(A) | 3K | — | $0 |
| Sep 9, 2025 | Corvese Brian | Director | Grant(A) | 3K | — | $0 |
| Sep 9, 2025 | Behner Peter | Director | Grant(A) | 3K | — | $0 |
| Sep 9, 2025 | Kadlec Robert Peter | Director | Grant(A) | 3K | — | $0 |
| Sep 2, 2025 | Behner Peter | Director | Grant(A) | 1K | $13.86 | $16K |
| Sep 2, 2025 | Corvese Brian | Director | Grant(A) | 1K | $13.86 | $18K |
| Sep 2, 2025 | Ryan Barbara | Director | Grant(A) | 1K | $13.86 | $18K |
| Sep 2, 2025 | Kadlec Robert Peter | Director | Grant(A) | 975 | $13.86 | $14K |
| Sep 2, 2025 | Wiinberg Ulf | Director | Grant(A) | 1K | $13.86 | $14K |
| Jun 2, 2025 | Ryan Barbara | Director | Grant(A) | 2K | $7.17 | $18K |
| Jun 2, 2025 | Kadlec Robert Peter | Director | Grant(A) | 2K | $7.17 | $14K |
| Jun 2, 2025 | Corvese Brian | Director | Grant(A) | 2K | $7.17 | $18K |
| Jun 2, 2025 | Wiinberg Ulf | Director | Grant(A) | 2K | $7.17 | $14K |
| Jun 2, 2025 | Behner Peter | Director | Grant(A) | 2K | $7.17 | $16K |
| Mar 3, 2025 | Corvese Brian | Director | Grant(A) | 2K | $8.79 | $18K |
| Mar 3, 2025 | Ryan Barbara | Director | Grant(A) | 2K | $8.79 | $18K |
| Mar 3, 2025 | Wiinberg Ulf | Director | Grant(A) | 2K | $8.79 | $14K |
| Mar 3, 2025 | Behner Peter | Director | Grant(A) | 2K | $8.79 | $16K |
| Mar 3, 2025 | Kadlec Robert Peter | Director | Grant(A) | 2K | $8.79 | $14K |
| Dec 1, 2024 | Wiinberg Ulf | Director | Grant(A) | 20K | $0.73 | $15K |
| Dec 1, 2024 | Behner Peter | Director | Grant(A) | 21K | $0.73 | $15K |
| Dec 1, 2024 | Corvese Brian | Director | Grant(A) | 24K | $0.73 | $18K |
| Dec 1, 2024 | Ryan Barbara | Director | Grant(A) | 24K | $0.73 | $18K |
| Dec 1, 2024 | Kadlec Robert Peter | Director | Grant(A) | 12K | $0.73 | $9K |
| Oct 30, 2024 | Kadlec Robert Peter | Director | Grant(A) | 42K | — | $0 |
| Sep 3, 2024 | Corvese Brian | Director | Grant(A) | 22K | $0.82 | $18K |
| Sep 3, 2024 | Wiinberg Ulf | Director | Grant(A) | 18K | $0.82 | $15K |
| Sep 3, 2024 | Behner Peter | Director | Grant(A) | 19K | $0.82 | $15K |
| Sep 3, 2024 | Ryan Barbara | Director | Grant(A) | 22K | $0.82 | $18K |
| Jun 3, 2024 | Corvese Brian | Director | Grant(A) | 18K | $0.99 | $18K |
| Jun 3, 2024 | Wiinberg Ulf | Director | Grant(A) | 15K | $0.99 | $15K |
| Jun 3, 2024 | Ryan Barbara | Director | Grant(A) | 18K | $0.99 | $18K |
| Jun 3, 2024 | Behner Peter | Director | Grant(A) | 15K | $0.99 | $15K |
| Mar 1, 2024 | Corvese Brian | Director | Grant(A) | 19K | $0.95 | $18K |
| Mar 1, 2024 | Ryan Barbara | Director | Grant(A) | 19K | $0.95 | $18K |
| Mar 1, 2024 | Behner Peter | Director | Grant(A) | 16K | $0.95 | $15K |
| Mar 1, 2024 | Wiinberg Ulf | Director | Grant(A) | 16K | $0.95 | $15K |
| Jan 16, 2024 | van Dijk Marcus Antonius | Chief Scientific Officer | Grant(A) | 171K | — | $0 |
| Jan 16, 2024 | van Dijk Marcus Antonius | Chief Scientific Officer | Grant(A) | 15K | — | $0 |
| Jan 16, 2024 | Buell Jennifer | Chief Executive Officer | Grant(A) | 500K | — | $0 |
| Jan 16, 2024 | Buell Jennifer | Chief Executive Officer | Grant(A) | 661K | — | $0 |
| Dec 1, 2023 | Behner Peter | Director | Grant(A) | 15K | $1.04 | $15K |
| Dec 1, 2023 | Wiinberg Ulf | Director | Grant(A) | 14K | $1.04 | $15K |
| Dec 1, 2023 | Corvese Brian | Director | Grant(A) | 17K | $1.04 | $18K |
| Dec 1, 2023 | Ryan Barbara | Director | Grant(A) | 17K | $1.04 | $18K |
| Oct 16, 2023 | Agenus Inc | 10% Owner | Buy(P) | 429 | $1.10 | $472 |
| Oct 13, 2023 | Agenus Inc | 10% Owner | Buy(P) | 19K | $1.10 | $21K |
| Oct 12, 2023 | Agenus Inc | 10% Owner | Buy(P) | 3K | $1.10 | $3K |
| Oct 11, 2023 | Buell Jennifer | Chief Executive Officer, Director | Other(J) | 696K | — | — |
| Oct 11, 2023 | Buell Jennifer | Chief Executive Officer, Director | Grant(A) | 696K | — | $0 |
| Oct 4, 2023 | Agenus Inc | 10% Owner | Buy(P) | 15K | $1.09 | $16K |
| Oct 3, 2023 | Buell Jennifer | Chief Executive Officer, Director | Tax withholding(F) | 65K | $0.94 | $61K |
| Oct 2, 2023 | Buell Jennifer | Chief Executive Officer, Director | Tax withholding(F) | 59K | $1.04 | $61K |
| Sep 29, 2023 | Buell Jennifer | Chief Executive Officer, Director | Tax withholding(F) | 25K | $1.15 | $29K |
| Sep 27, 2023 | Buell Jennifer | Chief Executive Officer | Option exercise(M) | 696K | — | — |
| Sep 27, 2023 | Buell Jennifer | Chief Executive Officer | Option exercise(M) | 696K | — | $0 |
| Sep 1, 2023 | Wiinberg Ulf | Director | Grant(A) | 10K | $1.46 | $14K |
| Sep 1, 2023 | Ryan Barbara | Director | Grant(A) | 12K | $1.46 | $18K |
| Sep 1, 2023 | Baldoni John | Director | Grant(A) | 10K | $1.46 | $14K |
| Sep 1, 2023 | Corvese Brian | Director | Grant(A) | 12K | $1.46 | $18K |
| Sep 1, 2023 | Behner Peter | Director | Grant(A) | 11K | $1.46 | $15K |
| Aug 29, 2023 | Agenus Inc | 10% Owner | Buy(P) | 30K | $1.52 | $45K |
| Aug 28, 2023 | Agenus Inc | 10% Owner | Buy(P) | 13K | $1.45 | $19K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: MiNK Therapeutics, Inc., SEC CIK 0001840229. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under INKT and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for INKT